MDxHealth (MDXH) Depreciation & Amortization (CF) (2023 - 2026)

MDxHealth has disclosed Depreciation & Amortization (CF) across 4 years of filings, most recently posting $1.1 million for Q1 2026.

• Depreciation & Amortization (CF) for Q1 2026 came in at $1.1 million, up 21.62% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.0 million (down 7.8% YoY), and the FY2025 annual result was $4.0 million, up 199.03% from the prior year.
• Depreciation & Amortization (CF) came in at $1.1 million for Q1 2026 at MDxHealth, up from $957000.0 in the prior quarter.
• In the past five years, Depreciation & Amortization (CF) ranged from a high of $1.1 million in Q1 2026 to a low of $455000.0 in Q4 2023.
• The 4-year median for Depreciation & Amortization (CF) is $863000.0 (2024), against an average of $833777.8.
• Peak annual rise in Depreciation & Amortization (CF) reached 89.67% in 2024, while the deepest fall reached 11.4% in 2024.
• MDxHealth's Depreciation & Amortization (CF) stood at $455000.0 in 2023, then soared by 89.67% to $863000.0 in 2024, then gained by 10.89% to $957000.0 in 2025, then increased by 17.55% to $1.1 million in 2026.
• The last three Depreciation & Amortization (CF) figures came in at $1.1 million (Q1 2026), $957000.0 (Q3 2025), and $946000.0 (Q2 2025), per Business Quant data.